Editas Medicine (EDIT) & NewLink Genetics (NASDAQ:NLNK) Head-To-Head Survey – registrarjournal.com
Editas Medicine (EDIT) & NewLink Genetics (NASDAQ:NLNK) Head-To-Head Surveyregistrarjournal.comIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein… Continue reading
